1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with olopatadine hydrochloride in 2 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (olopatadine hydrochloride) | Trials (olopatadine hydrochloride) | Recent Studies (post-2010) (olopatadine hydrochloride) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 317 | 103 | 111 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikemura, T; Ishii, H; Kitamura, S; Ohmori, K; Sasaki, Y | 1 |
Ikemura, T; Ishii, H; Kase, H; Kitamura, S; Manabe, H; Miki, I; Ohmori, K; Onuma, K; Sasaki, Y; Sato, S | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and olopatadine hydrochloride
Article | Year |
---|---|
[Effect of KW-4679, a novel antiallergic drug, on platelet-activating factor (PAF)-induced bronchoconstriction, airway hyperresponsiveness and pulmonary cell accumulation in guinea pigs].
Topics: Animals; Anti-Allergic Agents; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Dibenzoxepins; Guinea Pigs; Ketotifen; Leukocyte Count; Male; Olopatadine Hydrochloride; Platelet Activating Factor; Rabbits | 1995 |
KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils.
Topics: Acetyltransferases; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Autacoids; Dibenzoxepins; Enzyme Activation; Eosinophils; Guinea Pigs; Humans; Leukotriene B4; Lipids; Lipoxygenase Inhibitors; Male; Neutrophils; Olopatadine Hydrochloride; Platelet Activating Factor; Thromboxane B2; Thromboxane-A Synthase | 1996 |